Two studies of note reported that CD4+ T‐cell responses to EBNA1 were increased in peripheral blood of MS patients and had a Th1 phenotype with a broadened range of epitope specificities compared with healthy controls.54, 55. Here, CD4 is linked to myeloid sarcoma.